CEMIPLIMAB vs CERITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CEMIPLIMAB vs CERITINIB: Safety Overview
| Metric | CEMIPLIMAB | CERITINIB |
|---|---|---|
| Total FAERS Reports | 1,020 | 2,796 |
| Deaths Reported | 175 | 786 |
| Death Rate | 17.2% | 28.1% |
| Hospitalizations | 651 | 804 |
| Average Patient Age | 68.9 yrs | 55.6 yrs |
| % Female Patients | 36.6% | 55.1% |
| FDA Approval Date | N/A | Apr 29, 2014 |
| Manufacturer | Regeneron Pharmaceuticals, Inc. | Novartis Pharmaceuticals Corporation |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Discontinued |